In psoriatic patients, the expression of AIM2 and IL-1β is increased in keratinocytes from the skin lesion, and the activation of AIM2 in cultured keratinocytes leads to IL-1β release, suggesting that AIM2 is involved in the psoriasis pathogenesis [28]. This evidence concerns the gene AIM2 and psoriasis.